News

News
In the media

Investing in innovation – new digital approaches for a new decade

Read full story
In the media

Investing in innovation – new digital approaches for a new decade

Read full story
Partner news

Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test

Read full story
Partner news

Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform

Read full story
In the media

As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on

Read full story
In the media

BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs

Read full story
In the media

BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs

Read full story
In the media

As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on

Read full story
Partner news

resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology

Read full story
Partner news

ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes

Read full story
Partner news

Inivata Announces Strategic Collaboration and Investment from NeoGenomics

Read full story
Partner news

Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics

Read full story
Partner news

Philogen Announces Options Exercise by Janssen

Read full story
Partner news

RefleXion Raises $100 Million for Cancer Treatment Commercialization

Read full story
Partner news

Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies

Read full story